A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2021 Jul 28

PMID 34319046

Citations 2

Authors

Mohammad Mandegari

Seyed Alireza Dastgheib

Fatemeh Asadian

Seyed Hossein Shaker

Seyed Mostafa Tabatabaie

Shadi Kargar

Jalal Sadeghizadeh-Yazdi

Hossein Neamatzadeh

Affiliations

Soon will be listed here.

Abstract

Background: We conducted a comprehensive meta-analysis to explore the association of polymorphisms at XRCC1, XRCC2 and XRCC3 genes with susceptibility to thyroid cancer (TC).

Methods: We searched PubMed, EMBASE, Web of Science, and CNKI for relevant available studies. The pooled odds ratios (ORs) with 95% confidence intervals (CIs) were used to evaluate the strength of the associations.

Results: A total of 67 studies including 17 studies with 6,806 cases and 5,229 controls on XRCC1 Arg399Gln, 13 studies with 3,234 cases and 4,807 controls on XRCC1 Arg280His, 13 studies with 2,956 cases and 3,860 controls on XRCC1 Arg194Trp, five studies with 1,287 cases and 1,422 controls on XRCC2 Arg188His, 13 studies with 2,488 cases and 3,586 controls on XRCC3 Thr241Met, and six studies with 1,828 cases and 2,060 controls on XRCC3 IVS5-14 polymorphism were selected. Polled data revealed that the XRCC1 Arg399Gln, Arg280His, Arg194Trp, XRCC2 Arg188His and XRCC3 Thr241Met and IVS5-14 polymorphisms were not significantly associated with an increased risk of TC. Stratified analyses by ethnicity showed that the XRCC1 Arg399Gln polymorphism was associated with TC risk in Caucasians, but not in Asians.

Conclusions: Our meta-analysis indicated that the XRCC1 Arg399Gln, Arg280His, Arg194Trp, XRCC2 Arg188His, XRCC3 Thr241Met and IVS5-14 polymorphisms were not associated with risk of TC in the global population. Further well-designed investigations with large sample sizes are required to confirm our results.<br />.

Citing Articles

Polymorphisms of DNA Repair Genes in Thyroid Cancer.

Gielecinska A, Kciuk M, Kolat D, Kruczkowska W, Kontek R Int J Mol Sci. 2024; 25(11).

PMID: 38892180 PMC: 11172789. DOI: 10.3390/ijms25115995.

Association between XRCC2 Arg188His Polymorphism and Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.

Dastgheib S, Sayad S, Azizi S, Hajizadeh N, Asadian F, Karimi-Zarchi M Asian Pac J Cancer Prev. 2024; 25(1):43-55.

PMID: 38285766 PMC: 10911734. DOI: 10.31557/APJCP.2024.25.1.43.

References

Li S, Peng Q, Chen Y, You J, Chen Z, Deng Y . DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk: a meta-analysis. PLoS One. 2013; 8(9):e73448. PMC: 3767803. DOI: 10.1371/journal.pone.0073448. View

Ryu R, Tae K, Min H, Jeong J, Cho S, Lee S . XRCC1 polymorphisms and risk of papillary thyroid carcinoma in a Korean sample. J Korean Med Sci. 2011; 26(8):991-5. PMC: 3154355. DOI: 10.3346/jkms.2011.26.8.991. View

Jafari Nedooshan J, Forat Yazdi M, Neamatzadeh H, Shehneh M, Kargar S, Seddighi N . Genetic Association of XRCC1 Gene rs1799782, rs25487 and rs25489 Polymorphisms with Risk of Thyroid Cancer: a Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev. 2017; 18(1):263-270. PMC: 5563111. DOI: 10.22034/APJCP.2017.18.1.263. View

Lange S, Takata K, Wood R . DNA polymerases and cancer. Nat Rev Cancer. 2011; 11(2):96-110. PMC: 3739438. DOI: 10.1038/nrc2998. View

Chiang F, Wu C, Hsiao P, Kuo W, Lee K, Lin J . Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma. Clin Cancer Res. 2008; 14(18):5919-24. DOI: 10.1158/1078-0432.CCR-08-0906. View

Akulevich N, Saenko V, Rogounovitch T, Drozd V, Lushnikov E, Ivanov V . Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer. 2009; 16(2):491-503. DOI: 10.1677/ERC-08-0336. View

Rahbari R, Zhang L, Kebebew E . Thyroid cancer gender disparity. Future Oncol. 2010; 6(11):1771-9. PMC: 3077966. DOI: 10.2217/fon.10.127. View

Zhu Q, Bian J, Shen Q, Jiang F, Tang H, Zhang H . [Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma]. Zhonghua Liu Xing Bing Xue Za Zhi. 2004; 25(8):702-5. View

Ali A, AbdulKareem H, Al Anazi M, Reddy Parine N, Shaik J, Alamri A . Polymorphisms in DNA Repair Gene XRCC3 and Susceptibility to Breast Cancer in Saudi Females. Biomed Res Int. 2016; 2016:8721052. PMC: 4736606. DOI: 10.1155/2016/8721052. View

10.

Makazlieva T, Vaskova O, Majstorov V . Etiopathogenesis of Differentiated Thyroid Carcinomas. Open Access Maced J Med Sci. 2016; 4(3):517-522. PMC: 5042645. DOI: 10.3889/oamjms.2016.086. View

11.

Namazi A, Abedinzadeh M, Nourbaksh P, Neamatzadeh H . Association between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: a meta analysis of 5,193 cases and 6,645 controls. Asian Pac J Cancer Prev. 2015; 16(6):2263-8. DOI: 10.7314/apjcp.2015.16.6.2263. View

12.

Kamali M, Hamadani S, Neamatzadeh H, Mazaheri M, Shehneh M, Modaress Gilani M . Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev. 2017; 18(7):1743-1749. PMC: 5648374. DOI: 10.22034/APJCP.2017.18.7.1743. View

13.

Davies L, Morris L, Haymart M, Chen A, Goldenberg D, Morris J . AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYROID CANCER. Endocr Pract. 2015; 21(6):686-96. PMC: 4923940. DOI: 10.4158/EP14466.DSCR. View

14.

Fiore M, Oliveri Conti G, Caltabiano R, Buffone A, Zuccarello P, Cormaci L . Role of Emerging Environmental Risk Factors in Thyroid Cancer: A Brief Review. Int J Environ Res Public Health. 2019; 16(7). PMC: 6480006. DOI: 10.3390/ijerph16071185. View

15.

S Santos L, Branco S, Silva S, Azevedo A, M Gil O, Manita I . Polymorphisms in base excision repair genes and thyroid cancer risk. Oncol Rep. 2012; 28(5):1859-68. DOI: 10.3892/or.2012.1975. View

16.

Cannan W, Pederson D . Mechanisms and Consequences of Double-Strand DNA Break Formation in Chromatin. J Cell Physiol. 2015; 231(1):3-14. PMC: 4994891. DOI: 10.1002/jcp.25048. View

17.

La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F . Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2014; 136(9):2187-95. DOI: 10.1002/ijc.29251. View

18.

Siraj A, Al-Rasheed M, Ibrahim M, Siddiqui K, Al-Dayel F, Al-Sanea O . RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. J Endocrinol Invest. 2008; 31(10):893-9. DOI: 10.1007/BF03346438. View

19.

Halkova T, Dvorakova S, Sykorova V, Vaclavikova E, Vcelak J, Vlcek P . Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma. Cancer Biomark. 2016; 17(1):97-106. DOI: 10.3233/CBM-160622. View

20.

Baloch Z, LiVolsi V . Special types of thyroid carcinoma. Histopathology. 2017; 72(1):40-52. DOI: 10.1111/his.13348. View